SusanL FMcLellanMDMPH, FIDSA, FASTMH

Infectious Disease • Galveston, TX

Professor, Infectious Diseases, University of Texas Medical Branch

Join to view full profile

Dr. McLellan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. McLellan's full profile

Already have an account?

Office
301 University Blvd
Galveston, TX 77555
Phone+1 409-772-0644

Fax+1 409-772-4456

Education & Training

Emory University School of MedicineFellowship, Infectious Disease, 1993 - 1995
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1990 - 1993
University of Miami/Jackson Health SystemResidency, Pediatrics, 1990 - 1992
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Pediatrics, 1988 - 1990
Tulane University School of MedicineClass of 1988

Certifications & Licensure

CA State Medical License 1989 - Present
TX State Medical License 2018 - 2025
LA State Medical License 1988 - 2024
FL State Medical License 1991 - 1998
GA State Medical License 1993 - 1997

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

184 citations
Rickettsia parkeri Rickettsiosis and Its Clinical Distinction from Rocky Mountain Spotted Fever
Christopher D. Paddock, Richard W. Finley, Cynthia S. Wright, Howard N. Robinson, Barbara J. Schrodt
Clinical Infectious Diseases. 2008-11-01
28 citations
An Outbreak of Ebola Virus Disease in the Lassa Fever Zone.
Augustine Goba, S. Humarr Khan, Mbalu Fonnie, Mohamed Fullah, Alex Moigboi
The Journal of Infectious Diseases. 2016-10-15
61 citations
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.
Cameron R Wolfe, Kay M Tomashek, Thomas F Patterson, Carlos A Gomez, Vincent C Marconi
The Lancet. Respiratory Medicine. 2022-09-01

Press Mentions

Understanding the Recommendations for COVID-19 Booster ShotsFebruary 21st, 2023
The Hobby Center Enacts New COVID Safety Protocols and How History May Be on Vaccine Mandate’s SideSeptember 30th, 2021
Texas Averaging 16,000 COVID Cases a DayAugust 26th, 2021
Join now to see all